According to the latest market research study published by P&S Intelligence, the global pharmacovigilance market is poised for significant growth, with projections indicating a rise from USD 8,340.1 million in 2024 to USD 18,026.7 million by 2030, reflecting a CAGR of 13.9%. This expansion is primarily driven by the increasing incidence of adverse drug reactions (ADRs) and a heightened focus on drug safety and efficacy. Additionally, the integration of artificial intelligence (AI) and machine le